North America food enzymes market to witness over 6.1% CAGR up to 2024

The research report “Food Enzymes Market Size By Product (Proteases, Lipases, Carbohydrases [Amylases, Xylanases/Hemicellulase, Cellulase, Pectinase, Lactases], Polymerases & Nucleases, Phytases, Catalases), By Application (Beverages, Processed Food, Dairy, Bakery, Confectionary), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024” by Global Market Insights, Inc. says, Food enzymes Market size will surpass USD 3.6 billion by 2024.

Increasing consumer awareness regarding nutritional benefits offered by enzymes has resulted in increased product demand, thus driving the food enzymes market penetration. The strong application outlook for the food & beverage industry for product quality enhancement along with high acceptance from the bakery and confectionery applications to bread quality standardization and flour reduction level will escalate demand.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/2477

Numerous food processing units are extensively using these additives to attain environment-friendly processes, as these extracts are used as biocatalysts to increase the production rate. This leads to a considerable reduction in raw material wastage, resulting in shifting preference of the end-users. Several applications such as bakery, dairy, and confectionary are witnessing high adoption of protease, lactase, and carbohydrase owing to rising demand for extended product shelf-life and uniformity.

F&B industry has witnessed various trends, significantly impacting the food enzymes market growth. Fermentation of food is an emerging trend, that has gained traction among the industry participants. These products are fermented, that results in creation of a number of enzymes, intensifying their strength. Moreover, high usage of these additives for stabilizing the beverages and minimizing the off-odors will instigate immense growth potential in the coming years. However, excessive R&D costs and strict and critical guidelines to handle enzymes production and usage may hamper the industry growth over the next eight years.

Browse key industry insights spread across 500 pages with 1891 market data tables & 9 figures & charts from this 2018 report Vaccines Market in detail along with the table of contents at:

https://www.gminsights.com/industry-analysis/food-enzymes-market

Carbohydrases will acquire a major share in the industry crossing USD 1.8 billion sales by 2024. Growing demand for prominent carbohydrases type such as amylase, pectinase, lactase, and cellulase will remain a key factor driving demand. These ingredients are significant in F&B industry and witness high consumption regularly. Phytase will exhibit over 7% CAGR till 2024 owing to its benefits in absorption of vital materials including magnesium and calcium, as well as and reduction of phytic acid.

Beverages applications of food enzymes market are likely to dominate the industry, registering over 50 kilotons demand by 2024. Rising consumption of beverages among different class of societies across the globe will result in increased product penetration. Provision of benefits such as increased processing capacity and economy enhancement in beverage industry will further propel the industry growth. The bakery will grow significantly owing to high product usage for enhancing dough stability, maintaining bread quality, and ensuring proper browning of bread.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2477

North America is expected to capture highest share in the global food enzymes market and witness over 6.1% CAGR up to 2024. Rising trend for nutritional diet patterns, especially in U.S. will essentially support the regional growth. Increasing consumption of fortified meat, processed and canned products across the region has resulted in proliferating enzymes demand among the food manufacturer.

Asia Pacific food enzymes market will grow rapidly, witnessing over 7.5% CAGR from 2017 to 2024. Rising acceptance from various applications such as beverages, dairy, and RTE items along with high demand for convenience products will primarily drive the regional industry growth.

Royal DSM, Danisco, BASF, Lumis, Aumgene Biosciences, Enmex, Advanced Enzymes, and AB Group are among the noticeable participants in the food enzymes market. Other prominent industry players include Chr. Hansen, Enzyme Innovation, Thermo Fisher Scientific, Hayashibara Co., and Enzymes Solutions. Competitors are indulging in partnerships to strengthen their position in the industry.

Browse Related Reports:

Brewing Enzymes Market Size By Product (Amylases [Decotion Vessel, Mashing, Fermentation], Proteases [Conditioning Tank], Beta-glucanases [Decotion Vessel, Mashing, Fermentation], Xylanases [Mashing]) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2017 – 2024

https://www.gminsights.com/industry-analysis/brewing-enzymes-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

In-Vitro Colorectal Cancer Screening Tests Market to reach $1bn by 2024

Increasing prevalence of colon and rectal cancer coupled with growing awareness levels regarding genetic testing and advents in technology for development in cancer screening propels in-vitro colorectal cancer screening tests market growth. Approvals and launch of various instruments along with timely introduction of novel next-generation systems are determinants of significant business growth. In-Vitro Colorectal Cancer Screening Tests Market size is set to exceed USD 1 billion by 2024; according to a new research report by Global Market Insights.

The colorectal cancer screening has revealed to be effective technique in order to detect early colorectal cancer (CRC) as well as precancerous lesions. Numerous types of non-invasive tests are developed for the CRC screening thereby, upsurges the demand for CRC screening. In addition to enhancements in non-invasive tests for CRC screening are factors further propelling industry size growth.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/451

Chronic conditions such as inflammatory bowel disease, and Type 2 diabetes along with sedentary lifestyle, heavy alcohol consumption is on escalation and are related to colorectal cancer. Improved diagnostics tests and high occurrence of colorectal cancer will augment industry growth.

Inadequate reimbursement coverage coupled with lack of trained staff in the developing regions and dearth of uniform cancer screening guidelines in the Asia Pacific region will hamper business growth.

Fecal occult blood test (FOBT) test type segment dominated the market in 2016, on an account of widely preferred test due to FOBT being inexpensive and non-invasive as compared to sigmoidoscopy and colonoscopy. FOBT is also the foremost well-researched test for screening.

Browse key industry insights spread across 140 pages with 99 market data tables & 8 figures& charts from the report In-Vitro Colorectal Cancer Screening Tests Market in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/in-vitro-colorectal-cancer-screening-tests-market-report

CRC DNA screening test segment is anticipated to grow at a highest CAGR. The growth is attributable to factors such as, increasing prevalence of colon and rectal cancer coupled with availability of affordable technique. Screening for the CRC plays a significant role in the reduction of CRC related mortality. Moreover, coverage of health insurance for CRC screening fuels demand. The Medical Insurance (Medicare Part B) covers numerous types of CRC screening tests. Tests assist in finding the precancerous growths when treatment is effective. Additionally, one or more tests can be covered including, screening barium enema, multi-target stool DNA test, and screening colonoscopy.

Germany in-vitro colorectal cancer screening tests market is projected to witness robust business growth in foreseeable future. Escalating incidence of bowel cancer and increasing colonoscopy participation rates are factors propelling business growth in Germany. Surging use of screening tests as an aid to prevent bowel cancer along with lifestyle changes will boost industry growth.

Italy in-vitro CRC screening tests market is anticipated to exhibit highest CAGR due to increasing risk factors of cancer, coupled with growing elderly population base. Developments in diagnostic treatment and procedures along with increasing awareness levels among individuals regarding colon and rectal cancer are aspects stimulating business growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/451

China’s in-vitro colorectal cancer screening tests market will grow significantly as a result of escalating incidences of colorectal cancer and growing initiatives by government for establishing targeted prevention and prior detection programs. Furthermore, increasing risk factors of colorectal cancer and surging demand for safe endoscopy facilities are factors propelling business growth in India.

Some of the prominent business players operational in global in-vitro CRC screening tests market are Alere, Abbott Molecular, Eiken Chemical, Beckman Coulter, Epigenomics, Siemens Healthcare, Sysmex, Quest Diagnostics, Exact Sciences, OncoCyte Corporation-Bio time, EMD Millipore, GeneNews, BioMarCare Technologies, Immunostics, Qiagen, Kyowa Medex, Novigenix, Randox Laboratories, and R-Biopharm.

The industry players emphasize on development of cost-effective tests as well as tools for competent decision making and opting for effective treatment possibilities for colorectal cancer. For instance, in August 2016, Abbott Molecular, introduced Alinity, family of next-generation systems across clinical chemistry, immunoassay, hematology, plasma and blood screening, molecular diagnostics. These systems enable the company to cater towards its healthcare patient’s diagnostic requirements and provide advance care.

Browse Related Reports: 

Molecular Diagnostics Market Size By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In Situ Hybridization, Chips and microarrays, Mass spectrometry, Sequencing, Isothermal Amplification), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024

https://www.gminsights.com/industry-analysis/molecular-diagnostics-market-report

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Pharmacovigilance Market Application Development, Industry Trends, Forecast by 2017 – 2024

​Increasing adverse drug reactions across the globe will fuel need for pharmacovigilance services escalating pharmacovigilance market growth over forecast timeframe. Adverse drug reactions are among the common causes of death and morbidity within hospital settings. Moreover, as the adverse drug reactions are more prevalent in people aged 65 years and above, aging demographics in developed economies will further stimulate demand for drug monitoring services. Pharmacovigilance Market size is set to exceed USD 8 billion by 2024; according to a new research report by Global Market Insights.

Personalized medicine industry has witnessed rapid growth due to increased usage and acceptance in the field of cancer therapeutics. Pharmaceutical companies are increasingly focusing on development of personalized medicines to cater its increasing demand. Thus, growing need of personalized medicine will propel need for pharmacovigilance services for foreseeable future.

Request for a sample of this research report- https://www.gminsights.com/request-sample/detail/853

Regulatory authorities relentless efforts to bring harmonization in pharmacovigilance practices will impact the industry growth. However, dearth of skilled personnel coupled with the risk pertaining to data security will hamper business growth to some extent.

Phase III trial is estimated to grow at highest CAGR from 2017 to 2024 as compared to other clinical trial segments. Phase III clinical trials involves the assessment of drug’s safety, efficacy and risk benefit ratios. This stage is long and expensive due to the size of patient pool involved. There has been continues rise in failure rate at Phase III over the last decade.

Phase IV trial segment dominated pharmacovigilance market and trend is likely to continue in forthcoming years due to rising awareness and favorable regulations pertaining to post marketing surveillance.

In house pharmacovigilance provides enhanced data security and data confidentiality. However, state of art infrastructure and skilled staff required for in house pharmacovigilance is difficult to maintain and comes with the additional operational cost. Moreover, pharmacovigilance diverts focus of manufacturers from their core activities. As a result, manufacturers are increasingly outsourcing pharmacovigilance activities to specialized business players in the developing countries. Moreover, outsourcing further saves cost for manufacturers as the pharmacovigilance service providers in Asia Pacific region costs significantly less.

Browse key industry insights spread across 160 pages with 73 market data tables & 9 figures& charts from the report Pharmacovigilance Market in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/pharmacovigilance-market

Japan dominated Asia Pacific pharmacovigilance market due to robust adverse drug reaction reporting system and healthcare infrastructure. The population of Japan is aging rapidly. As the risk of adverse drug reaction is significantly higher in aged population, need for adverse drug reaction monitoring and reporting will also increase with the aging population. Large consumption of prescription medicine and increase level of accessibility to healthcare services will further escalate industry growth over forecast period.

India has well established presence of many industry players including TCS, Cognizant and more. The cost of pharmacovigilance services in India is significantly lower compared to cost in developed economies like U.S. UK etc. As a result, the manufacturers are increasingly outsourcing pharmacovigilance activities to these firms in India. This trend is likely to continue over forecast timeframe rendering positive impact on industry growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/853

Some of the key industry players operating in global Pharmacovigilance market are Accenture, Boehringer Ingelheim, Bristol-Myers Squibb, Cognizant Technology Solutions Corporation, F. Hoffmann-La Roche, GlaxoSmithKline, IQVIA (QuintilesIMS), IBM Corporation, Infosys, Janssen Research & Development, Ipca Laboratories, ITclinical, Laboratory Corporation of America Holdings, Novartis AG, Pfizer, Sanofi Aventis, TCS, and Wipro.

Industry players are putting efforts to develop new innovative and technologically advanced platform that improves pharmacovigilance service capabilities. For instance, in October 2017, TCS launched Connected Clinical Trials (CCT), an innovative platform that improves efficiency of clinical supply process.

Browse Related Reports:

Precision Medicine Market Size By Technology (Big Data Analytics, Gene Sequencing, Drug Discovery, Bioinformatics, Companion Diagnostics), By Application (Oncology, CNS, Immunology, Respiratory), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Scandinavia, Italy, Japan, China, India, Singapore, Mexico, Brazil, South Africa, UAE, Qatar, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

https://www.gminsights.com/industry-analysis/precision-medicine-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
​Web:https://www.gminsights.com
​Blog:https://gminsights.wordpress.com